Corrado Corti, PhD, is a senior researcher at the Center for Biomedicine at the European Academy of Bolzano, Italy. He got his degree in pharmaceutical chemistry and technology from the University of Milan, Italy and earned his PhD from the University of Cambridge (UK) working on regulation of transcription and protein expression of glutamate receptors in human brain of schizophrenics. His main scientific interests are molecular and functional studies aimed to identify and validate novel targets for understanding and treatment of neurological diseases, especially neurodegenerative and psychiatric diseases. He has been investigating different types of targets (GPCRs, ion channels, kinases) using expression analysis, cellular models and genetically modified pre-clinical models. He has been leading multi-discipline drug discovery projects (drug addiction, schizophrenia, sleep) from target identification and validation to candidate selection prior to Phase I initiation.